Search Results

Press Releases

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

November 19, 2024

·

4 min read

Deals

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion.

September 17, 2021

·

5 min read

Deals

PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) today announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion in a combination of cash and stock, subject to certain adjustments.

July 26, 2021

·

8 min read

Business

BioLegend Moves Global Headquarters to Newly Constructed, State-of-the-Art Campus in San Diego, California

BioLegend Campus Inauguration Symposium focused on Cancer Immunotherapy features Nobel Laureate and World-Renowned Immunologists

May 9, 2019

·

4 min read

Business

BioLegend and New York Genome Center Enter into Exclusive Global License and Research Agreement for CITE-seq, a Novel Technique for Multidimensional Single Cell Analysis

BioLegend (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq technology for use in the research field.

January 11, 2018

·

4 min read

Business

PerkinElmer Continues Rapid Life Science Growth with Massive $5.25B Acquisition

It’s been a long season of acquisitions for PerkinElmer. Now in its largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy biomedical research tool company BioLegend.

July 26, 2021

·

2 min read

·

Kate Goodwin

Business

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

The newly developed applications have potential to accelerate disease research and drug discovery in oncology, neurology, infections disease, and immunology in addition to enhancing cell atlas research initiatives.

July 31, 2018

·

5 min read

Genetown

Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024

Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held in Boston from February 3-7 in booth #408.

February 2, 2024

·

5 min read

Biotech Beach

Scale Biosciences Unveils Platform for Dramatic Scaling of Single-Cell Experiments and Announces Partnerships to Drive Ease of Use and Enable New Biological Insights

Scale Biosciences today announced its development of a new two plate workflow to enable dramatic scaling of its technology and a first set of partners to improve ease of use and enable the deployment of their portfolio across new omics applications.

February 5, 2024

·

5 min read

Biotech Beach

BioLegend Joins The Resource Identification Initiative To Improve Research Reproducibility

September 23, 2016

·

2 min read